Speeding access to precision oncology drugs: How are we doing with biomarker-driven drug approvals?

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)113-114
Number of pages2
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2020

ASJC Scopus subject areas

  • Oncology

Cite this